marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Rigel Pharmaceuticals Financial Ratios 2011-2024 | RIGL
Annual Financial Ratios Rigel Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.3 | -4.4 | -24.4 | -20.7 | -5.9 | -4.9 | -6.5 | -2.8 | -4.7 | -2.0 | -3.1 | -4.8 | -7.2 |
P/S |
2.2 | 2.1 | 2.9 | 5.7 | 6.6 | 7.8 | 112.4 | 9.6 | 8.4 | 22.0 | 38.5 | 212.9 | 129.5 |
EPS |
-0.1 | -0.3 | -0.1 | -0.2 | -0.4 | -0.4 | -0.6 | -0.7 | -0.6 | -1.0 | -1.0 | -1.3 | -1.4 |
EV (Enterprise Value) |
372 M | 379 M | 555 M | 660 M | 463 M | 301 M | 484 M | 202 M | 240 M | 192 M | 272 M | 467 M | 617 M |
EBITDA per Share |
-0.11 | -0.32 | -0.07 | -0.17 | -0.409 | -0.449 | -0.627 | -0.668 | -0.569 | -1.01 | -0.976 | -1.29 | -1.33 |
EV/EBITDA |
-28.4 | -21.4 | -5.5 | -3.8 | -5.9 | -2.8 | -4.0 | -1.9 | -3.0 | -4.6 | -7.1 | ||
PEG |
-0.31 | -0.11 | 0.76 | 1.22 | -0.64 | -0.17 | -0.43 | 0.11 | -0.11 | 1.02 | -0.14 | -1.65 | 0.02 |
P/B |
-9.1 | -18.7 | 14.4 | 18.1 | 7.3 | 3.2 | 5.0 | 3.6 | 2.7 | 1.4 | 1.3 | 1.7 | 2.6 |
P/CF |
-45.1 | -3.5 | 74.3 | -11.8 | -9.1 | -5.8 | -6.5 | -2.6 | -10.2 | -2.6 | -3.2 | -5.4 | -8.6 |
ROE % |
87.60 | 430.18 | -58.98 | -87.42 | -124.30 | -64.14 | -77.49 | -125.79 | -56.32 | -70.89 | -42.75 | -34.19 | -36.41 |
ROA % |
-21.40 | -43.62 | -10.71 | -26.95 | -45.33 | -50.67 | -65.48 | -88.59 | -39.06 | -58.98 | -39.38 | -31.88 | -33.44 |
ROCE % |
71.54 | 407.98 | -41.14 | -85.15 | -77.32 | -65.26 | -79.00 | -115.17 | -52.83 | -65.13 | -40.69 | -33.37 | -35.17 |
Current Ratio |
0.8 | 0.9 | 1.2 | 1.4 | 2.0 | 4.9 | 6.4 | 3.4 | 3.8 | 10.7 | 21.4 | 24.8 | 21.7 |
DSO |
110.7 | 84.7 | 38.5 | 43.8 | 62.2 | 33.4 | - | - | 2.6 | 254.4 | 293.5 | - | - |
DIO |
375.8 | 1641.8 | 1390.9 | 610.1 | 545.5 | 1137.0 | - | - | - | - | - | - | - |
DPO |
761.1 | 2744.6 | 1264.2 | 1602.5 | 1672.7 | 8127.9 | - | - | - | - | - | - | - |
Operating Cycle |
486.4 | 1726.5 | 1429.4 | 653.9 | 607.7 | 1170.4 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-274.6 | -1018.1 | 165.2 | -948.6 | -1065.0 | -6957.5 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Rigel Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.71 | -0.06 | -0.05 | -0.33 | -0.38 | -0.08 | - | -0.11 | -0.08 | -0.16 | - | -0.12 | -0.08 | 0.23 | -0.11 | -0.08 | -0.1 | 0.13 | -0.1 | -0.07 | -0.12 | -0.11 | 0.02 | -0.14 | -0.16 | -0.17 | -0.18 | -0.14 | -0.16 | -0.13 | -0.16 | -0.24 | -0.15 | -0.19 | -0.14 | -0.08 | -0.16 | -0.21 | -0.25 | -0.24 | -0.29 | -0.25 | -0.19 | -0.27 | -0.26 | -0.29 | -0.3 | -0.36 | -0.35 | -0.32 | -0.36 | -0.25 | -0.37 | -0.4 |
EBITDA per Share |
0.83 | 0.06 | -0.04 | -0.24 | -0.29 | -0.07 | - | -0.1 | -0.08 | -0.15 | - | -0.11 | -0.08 | 0.25 | - | -0.08 | -0.1 | 0.13 | - | -0.07 | -0.13 | -0.11 | - | -0.14 | -0.16 | -0.17 | - | -0.14 | -0.16 | -0.14 | - | -0.23 | -0.14 | -0.19 | - | -0.06 | -0.15 | -0.2 | - | -0.22 | -0.28 | -0.25 | - | -0.25 | -0.25 | -0.29 | - | -0.33 | -0.33 | -0.32 | - | -0.23 | -0.35 | -0.39 |
ROE % |
-37.50 | 70.84 | 123.20 | 193.14 | 271.24 | 614.70 | 59.19 | 17.01 | -121.16 | -508.38 | -12.03 | -68.56 | -68.04 | -36.97 | -24.98 | -0.41 | -51.09 | -132.86 | -228.00 | -193.10 | -167.84 | -142.30 | -131.79 | -160.43 | -145.14 | -133.92 | -126.95 | -129.57 | -175.24 | -197.33 | -213.85 | -199.41 | -109.25 | -68.15 | -56.32 | -59.80 | -68.83 | -73.40 | -70.89 | -61.62 | -56.73 | -47.86 | -42.75 | -43.46 | -40.83 | -38.45 | -34.19 | -36.30 | -35.09 | -35.62 | -36.41 | -7.59 | -9.09 | -8.80 |
ROA % |
-3.35 | -17.89 | -28.04 | -37.99 | -49.52 | -62.29 | -53.29 | -64.52 | -40.88 | -47.73 | 0.20 | -17.23 | -18.84 | -8.66 | -7.70 | -1.93 | -22.76 | -51.97 | -83.14 | -69.17 | -88.48 | -98.49 | -104.10 | -128.14 | -118.91 | -111.94 | -107.27 | -105.50 | -130.38 | -141.11 | -150.61 | -140.29 | -76.72 | -47.61 | -39.06 | -43.88 | -52.41 | -58.32 | -58.98 | -51.99 | -48.94 | -42.54 | -39.38 | -40.14 | -37.81 | -35.72 | -31.88 | -33.69 | -32.46 | -32.83 | -33.44 | -6.97 | -8.35 | -8.08 |
ROCE % |
-61.51 | 53.26 | 107.21 | 178.00 | 256.76 | 590.63 | 59.08 | 19.24 | -113.37 | -485.13 | -5.66 | -46.16 | -46.83 | -78.79 | -29.82 | -52.19 | -34.05 | -22.59 | -96.17 | -118.35 | -118.16 | -102.27 | -68.45 | -86.19 | -81.76 | -77.21 | -53.06 | -94.38 | -117.96 | -123.55 | -98.05 | -105.47 | -71.57 | -62.06 | -42.67 | -59.08 | -68.07 | -72.62 | -53.71 | -65.20 | -60.29 | -51.43 | -34.83 | -43.67 | -41.02 | -38.64 | -25.51 | -33.15 | -31.95 | -32.47 | -25.60 | -7.64 | -9.13 | -8.83 |
Current Ratio |
0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
49.1 | 69.9 | 78.9 | 72.0 | 85.2 | 122.0 | - | 31.6 | 23.3 | 83.7 | - | 68.5 | 277.2 | 89.1 | 79.0 | 79.3 | 91.0 | 21.3 | 59.9 | 44.2 | 88.7 | 51.3 | 9.8 | 76.5 | 208.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
73.0 | 237.9 | 285.9 | 607.9 | 927.7 | 943.1 | - | 1298.7 | 297.9 | 5045.1 | - | 4190.2 | 4873.7 | 1239.5 | - | 1067.6 | 535.7 | 880.7 | - | 398.6 | 397.3 | 958.5 | - | 1182.3 | 2719.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
56.5 | 250.4 | 389.2 | 476.4 | 489.6 | 1345.1 | - | 496.6 | 203.2 | 3170.8 | - | 1460.3 | 2399.4 | 1270.9 | - | 2416.2 | 1212.4 | 2313.3 | - | 1222.2 | 1218.2 | 4495.6 | - | 8451.9 | 19439.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
122.1 | 307.8 | 364.8 | 679.8 | 1012.9 | 1065.0 | - | 1330.3 | 321.2 | 5128.9 | - | 4258.8 | 5150.9 | 1328.6 | 79.0 | 1146.9 | 626.7 | 902.0 | 59.9 | 442.8 | 485.9 | 1009.8 | 9.8 | 1258.8 | 2927.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
65.5 | 57.4 | -24.4 | 203.5 | 523.3 | -280.0 | - | 833.7 | 118.0 | 1958.1 | - | 2798.5 | 2751.5 | 57.7 | 79.0 | -1269.3 | -585.7 | -1411.3 | 59.9 | -779.4 | -732.3 | -3485.7 | 9.8 | -7193.1 | -16511.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency